Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A Current Cash

As of the most recent data (March 2026), FBIOP shows a current cash of $260M. That compares with $91M in the prior-year period — up 180.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FBIOP's current cash is now $260M (was $91M) — a 180.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A is outperforming or lagging.

Tracking FBIOP's current cash over time shows whether Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $260M That compares with $91M in the prior-year period — up 180.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $260M) with ownership activity and broader fundamentals.

Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's current cash is $260M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.